Bml Capital Management, LLC Design Therapeutics, Inc. Transaction History
Bml Capital Management, LLC
- $149 Billion
- Q1 2024
A detailed history of Bml Capital Management, LLC transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 879,478 shares of DSGN stock, worth $3.88 Million. This represents 2.37% of its overall portfolio holdings.
Number of Shares
879,478
Previous 1,029,478
14.57%
Holding current value
$3.88 Million
Previous $2.73 Billion
29.92%
% of portfolio
2.37%
Previous 2.07%
Shares
2 transactions
Others Institutions Holding DSGN
# of Institutions
95Shares Held
30.5MCall Options Held
100Put Options Held
100-
Sr One Capital Management, LP6.53MShares$28.8 Million8.85% of portfolio
-
Logos Global Management LP San Francisco, CA5.03MShares$22.2 Million1.89% of portfolio
-
Black Rock Inc. New York, NY2.27MShares$10 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.66MShares$7.33 Million0.08% of portfolio
-
Tang Capital Management LLC San Diego, CA1.48MShares$6.53 Million0.73% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $246M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...